[HTML][HTML] MicroRNAs in ovarian carcinomas
N Dahiya, PJ Morin - Endocrine-related cancer, 2010 - erc.bioscientifica.com
The new incretin-based therapies, dipeptidyl peptidase-4 (DPP4) inhibitors and glucagon
like peptide 1 (GLP1) receptor agonists are widely used for the treatment of type 2 diabetes …
like peptide 1 (GLP1) receptor agonists are widely used for the treatment of type 2 diabetes …
MicroRNAs in ovarian carcinomas
N Dahiya, PJ Morin - Endocrine-related cancer, 2010 - pubmed.ncbi.nlm.nih.gov
The molecular mechanisms involved in epithelial ovarian cancer initiation and progression
are just beginning to be elucidated. In particular, it has become evident that microRNAs …
are just beginning to be elucidated. In particular, it has become evident that microRNAs …
[HTML][HTML] MicroRNAs in ovarian carcinomas
N Dahiya, PJ Morin - Endocrine-related cancer, 2010 - ncbi.nlm.nih.gov
The molecular mechanisms involved in epithelial ovarian cancer initiation and progression
are just beginning to be elucidated. In particular, it has become evident that microRNAs …
are just beginning to be elucidated. In particular, it has become evident that microRNAs …
MicroRNAs in ovarian carcinomas
N Dahiya, PJ Morin - Endocrine-Related Cancer, 2010 - cir.nii.ac.jp
抄録< jats: p> The molecular mechanisms involved in epithelial ovarian cancer initiation and
progression are just beginning to be elucidated. In particular, it has become evident that …
progression are just beginning to be elucidated. In particular, it has become evident that …
MicroRNAs in ovarian carcinomas.
N Dahiya, PJ Morin - Endocrine-related Cancer, 2010 - europepmc.org
The molecular mechanisms involved in epithelial ovarian cancer initiation and progression
are just beginning to be elucidated. In particular, it has become evident that microRNAs …
are just beginning to be elucidated. In particular, it has become evident that microRNAs …